Financial News Feed

Stronger Sell Today ACOR ranks #4867 as SELL CANDIDATE #4867 Weaker Sell

Acorda Therapeutics stock forecast

ACOR stock forecast

Acorda Therapeutics Enters Oversold Territory
02:15pm, Thursday, 13'th Jun 2019
Acorda Therapeutics, Inc. (ACOR) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock....

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 12) BIOFRONTERA AG/ADR (NASDAQ: BFRA ) BIO-TECHNE Corp (NASDAQ: TECH ) EXACT Sciences Corporation (NASDAQ: EXAS ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 12) Acorda Therapeutics Inc (NASDAQ: ACOR ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Arbutus Biopharma Corp (NASDAQ: ABUS ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) BRAINSWAY LTD/S ADR (NASDAQ: BWAY ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) Melinta Therapeutics Inc (NASDAQ: MLNT ) Minerva Neurosciences Inc (NASDAQ: NERV ) Navidea Biopharmaceuticals Inc (NYSE: NAVB ) NextCure Inc (NASDAQ: NXTC ) Novavax, Inc. (NASDAQ: NVAX ) Novus Therapeutics Inc (NASDAQ: NVUS ) Obseva SA (NASDAQ: OBSV ) RA Medical Systems Inc (NYSE: RMED ) Sellas Life Sciences Group Inc (NASDAQ: SLS ) Sensus Healthcare Inc (NASDAQ: SRTS ) Sierra Oncology Inc (NASDAQ: SRRA ) Unum Therapeutics Inc (NASDAQ: UMRX ) Zomedica Pharmaceuticals Corp (NYSE: ZOM ) Stock In Focus Savara's Pulmonary Disease Drug Does Not Meet Primary Endpoint In Late-stage Study Savara Inc (NASDAQ: SVRA ) said a Phase 3 study dubbed IMPALA that evaluated its …...

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 6) BIOFRONTERA AG/ADR (NASDAQ: BFRA ) BIO-TECHNE Corp (NASDAQ: TECH )(announced a deal to buy University of Minnesota startup B-MoGen technology) Blueprint Medicines Corp (NASDAQ: BPMC ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 6) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aduro BioTech Inc (NASDAQ: ADRO ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Aptinyx Inc (NASDAQ: APTX ) Axovant Gene Therapies Ltd (NASDAQ: AXGT )(reported six-month follow-up data from the first dose cohort in the Phase 2 trial of AXO-Lenti-PD for the treatment of Parkinson's disease and also issued pipeline update) Bellicum Pharmaceuticals (NASDAQ: BLCM ) Caladrius Biosciences Inc (NASDAQ: CLBS ) Cellectis SA (NASDAQ: CLLS ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Evolent Health Inc (NYSE: EVH ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Hemispherx BioPharma, Inc (NYSE: HEB ) IMMURON LTD/S ADR (NASDAQ: IMRN ) IMMUTEP LTD/S ADR (NASDAQ: IMMP ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) MOTIF BIO PLC/S ADR (NASDAQ: MTFB ) Navidea Biopharmaceuticals Inc (NYSE: NAVB ) Neuronetics Inc (NASDAQ: STIM ) Puma Biotechnology Inc (NASDAQ: PBYI ) Seres Therapeutics Inc (NASDAQ: …...

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 5) Array Biopharma Inc (NASDAQ: ARRY ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) BIOFRONTERA AG/ADR (NASDAQ: BFRA ) EXACT Sciences Corporation (NASDAQ: EXAS ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Misonix, Inc. (NASDAQ: MSON ) Repligen Corporation (NASDAQ: RGEN ) Uniqure NV (NASDAQ: QURE ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on June 5) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Arbutus Biopharma Corp (NASDAQ: ABUS ) Caladrius Biosciences Inc (NASDAQ: CLBS ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) ChemoCentryx Inc (NASDAQ: CCXI )(moved in sympathy with its rival, which has a competing drug) Collegium Pharmaceutical Inc (NASDAQ: COLL ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Cyclerion Therapeutics Inc (NASDAQ: CYCN ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Harvard Bioscience, Inc....

Read more

Acorda (ACOR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 30) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Misonix, Inc. (NASDAQ: MSON ) Repligen Corporation (NASDAQ: RGEN ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 30) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Abeona Therapeutics Inc (NASDAQ: ABEO ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Advaxis, Inc. (NASDAQ: ADXS ) Alkermes Plc (NASDAQ: ALKS ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Emergent Biosolutions Inc (NYSE: EBS ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Insys Therapeutics Inc (NASDAQ: INSY ) Minerva Neurosciences Inc (NASDAQ: NERV ) Mylan NV (NASDAQ: MYL ) Myovant Sciences Ltd (NYSE: MYOV )(announced $100 million worth of common stock offering) Neuronetics Inc (NASDAQ: STIM ) Seres Therapeutics Inc (NASDAQ: MCRB ) Teligent Inc (NASDAQ: TLGT ) Urogen Pharma Ltd (NASDAQ: URGN ) Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) Theravance Biopharma Inc (NASDAQ: TBPH ) Zafgen Inc (NASDAQ: ZFGN ) ( reacted to safety concerns over its diabetes drug following the Type A meeting with FDA) Stock In Focus Merrimack Board Decides Against Sale Following Strategic Review Following the completion of a strategic review, Merrimack Pharmaceuticals Inc (NASDAQ: MACK ) said its board has decided to restructure the company such that its …...

Read more

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news....

Read more

ACOR earnings call for the period ending March 31, 2019....

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 1) Alcon AG (NYSE: ALC ) (announced presentation of new clinical data and innovative technology at the Cataract Refractive Suite during the American Society of Cataract and Refractive Surgery) Down In The Dumps (Biotech stocks hitting 52-week lows on May 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Athenex Inc (NASDAQ: ATNX ) Auris Medical Holding Ltd (NASDAQ: EARS )(began to trade on a reverse stock-split adjusted basis) Caladrius Biosciences Inc (NASDAQ: CLBS ) Eyegate Pharmaceuticals Inc (NASDAQ: EYEG ) Heron Therapeutics Inc (NASDAQ: HRTX )(stymied by a CRL issued for its post-operative pain medication) KemPharm Inc (NASDAQ: KMPH ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) Psychemedics Corp. (NASDAQ: PMD ) Strongbridge Biopharma plc (NASDAQ: SBBP ) (reacted to its first quarter results) Related Link: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Stock In Focus FDA Okays Sanofi's Dengue Vaccine With Restrictions Sanofi SA (NASDAQ: SNY ) said the FDA approved its Dengvaxia for the prevention of dengue disease caused by serotypes 1-4 of the virus in individuals 9 through 16 years of age living in endemic areas of the U.S. with a lab-documented prior infection....

Read more

No summary available....

Read more

No summary available....

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 30) VolitionRX Ltd (NYSE: VNRX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE ) Down In The Dumps (Biotech stocks hitting 52-week lows on April 30) Acorda Therapeutics Inc (NASDAQ: ACOR ) Gamida Cell Ltd (NASDAQ: GMDA ) KemPharm Inc (NASDAQ: KMPH ) Meridian Bioscience, Inc. (NASDAQ: VIVO )(announced an agreement to acquire the business of GenePOC, a Canadian provider of molecular diagnostic instruments and assays) Outlook Therapeutics Inc (NASDAQ: OTLK ) Unum Therapeutics Inc (NASDAQ: UMRX ) Stock In Focus FDA Hands Out Complete Response Letter For Nabriva's Urinary Tract Infection Drug Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV ) received a complete response letter, or CRL, from the FDA for its NDA for Contepo, chemically fosfomycin, injection for treating complicated urinary tract infections, including acute pyelonephritis....

Read more

Acorda (ACOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 15) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN )(the company is said to explore a potential sale ) Medtronic PLC (NYSE: MDT ) Vermillion, Inc. (NASDAQ: VRML ) Down In The Dumps (Biotech stocks hitting 52-week lows on April 15) Achaogen Inc (NASDAQ: AKAO )(announced bankruptcy filing) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aethlon Medical, Inc. (NASDAQ: AEMD ) Assembly Biosciences Inc (NASDAQ: ASMB )(presented interim mid-stage results of its hepatitis B virus treatment candidate ABI-H0731) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) Conatus Pharmaceuticals Inc (NASDAQ: CNAT )(announced Phase 2 clinical trial evaluating emricasan in NASH patients with cirrhosis and severe portal hypertension) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Imv Inc (NASDAQ: IMV ) Sienna Biopharmaceuticals Inc (NASDAQ: SNNA ) Vaxart Inc (NASDAQ: VXRT ) Verastem Inc (NASDAQ: VSTM ) See Also: The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs Stock In Focus Motif Says New Iclaprim Data Shows Comparable Efficacy With Standard-of-care MOTIF BIO PLC/S ADR (NASDAQ: MTFB ) presented additional data for iclaprim at the 28th European Congress of Clinical Microbiology and Infectious Diseases, which showed it had comparable efficacy to vancomycin in treating acute bacterial skin and skin structure infection, or ABSSSI, lesions....

Read more

Acorda (ACOR) aims to boost sales with the launch of its newly FDA-approved Parkinson's disease drug, Inbrija. The company's pipeline looks promising as well....

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank